Peterson Amy C. 4
4 · CytomX Therapeutics, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
Peterson Amy C.
EVP, Chief Development Officer
Transactions
- Sale
Common Stock
2023-03-16$1.98/sh−4,257$8,425→ 58,433 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 30,000 restricted stock units.